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2Additional information
Details of ethics committee approval for each study (approval ID):
London studies: East London and the City Health Authority Research Ethics Committee (REC) (P/97/250); UCL
Institute of Child Health/Great Ormond Street Hospital REC (96EB23; 05/Q0508/141); North Thames Multi-centre
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Approval date: 22 September 2010; Hospital Vall d’Hebron: “Comité Ético de Investigación Clínica del Hospital
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Lisbon study: Lisbon REC (Approval date: December 2005)
Statistical methods
Descriptive characteristics are shown as mean (SD) or median (range) for the continuous variables and as n (%) for
the categorical ones. Multiple fractional polynomials[1] whereby a combination of integer or fractional power terms
are fitted to produce a polynomial equation, were used to identify the most suitable transformation in any
combination of the independent variables (i.e. height, weight, age) when modelling lung function outcomes to
achieve normality of the residuals. R package “mfp” (Multivariable Fractional Polynomials) was used for this purpose
(original by Gareth Ambler and modified by Axel Benner (2014), R package version 1.5.0.). The “nlme” package in R
(version 3.1-117) was used to check the models and the distributions of residuals using selected mfp transformations
taking into account repeated measures of individuals nested within centres by applying a random intercept model.
Test occasions (i.e. repeat assessments within individuals) were not included as main effects in the fixed part of the
equation as not all four centres had repeated measurements. Random slope models were not tested.
Reference equations for raised volume rapid thoraco-abdominal compression (RVRTC) outcomes were then
constructed as described [2,3] with the LMS (lambda-mu-sigma) method[4] fitting the best polynomial combination
as indicated previously, using the GAMLSS package in R.[5]. This method is an extension of the regression analysis
that includes three components: 1) skewness (lambda, L), which models the departure of variables from normality
using a Box-Cox transformation; 2) median (mu, M) or predicted value; and 3) coefficient of variation (sigma, S),
which models the spread of values around the median and adjusts for any non-uniform dispersion. The three
quantities are allowed to change with length and/or age, to reflect changes in the distribution as children grow. The
L, M and S coefficients are combined algebraically to convert individual observations to z-scores: z-score =
((measurement/M)L – 1)/(L x S).[4] Residual plots from multilevel models were used to check the skewness of the
distribution. When no skewness was indicated, L was fixed at 1. Indication of skewness was present for FEV0.5/FVC
and FEF25-75. This was not found to be dependent on either age or length (transformed as previously indicated from
polynomials) using the LMS method. Spread dependency on age and length (transformed as previously indicated
from polynomials) was tested in the LMS method.
3Normality of the residuals was tested using histograms and Q-Q plots, while a plot of the residuals vs the fitted
values from each model was used to check the assumption of homoscedasticity. Goodness of fit was assessed using
the Schwarz Bayesian criterion, which compares consecutive models directly while adjusting for increased
complexity to determine the simplest model with best fit.[6] Since RASP data were only available from London, and
the distribution of age and body size differed in the two datasets, the decision was made to derive separate
prediction equations for Jaeger and RASP equipment.
Modelling was performed using R v.3.1.0 incorporating packages as given previously. IBM SPSS Statistics v.22 was
used for data inspection, distribution and descriptive statistics.
RESULTS
Data exclusions: To facilitate development of robust and reliable reference ranges for RVRTC outcomes based on
sufficient sample size with relatively even spread over a wide range of age and body size in healthy infants, we
excluded a few data points which were at the extremes of length and age range.
Despite being recruited from the same area of London and measured by the same team of respiratory physiologists,
the children studied using Jaeger equipment were significantly taller and heavier than those tested a decade earlier
using RASP. A thorough investigation of background details for the two cohorts revealed no specific cause for this
difference which may simply be attributable to chance due to the relatively small sample size and the fact that
differences of up to 0.5 z-scores can occur by chance when comparing populations with less than 300 subjects.[7]
RASP vs. Jaeger®
When plotted according to equipment, there was relatively good overlay for FVC and FEV0.5 among younger children
but RASP FEF25-75 were significantly higher than Jaeger® data (Figure S1). Initial attempts to model all the data by
including equipment as an independent variable were not successful in achieving adequate fit. As the distribution of
RASP and Jaeger® data were markedly different, with more RASP data being available from younger infants,
equipment-specific reference equations were derived separately for RASP and Jaeger® data. Equations for the more
widely available Jaeger® equipment have been presented in the main manuscript. The following section focusses on
equations for interpreting RASP data, which are of relevance to laboratories which have previously collected data
with this device and are therefore particularly relevant for ongoing longitudinal follow up studies into later
childhood.
4Figure S1 RVRTC outcomes according to equipment
While there was reasonable overlay for FEV0.5 and FVC among younger infants, for any given length, FEF25-75 data
were considerably lower for Jaeger® data than RASP, necessitating the use of separate reference equations.
Prediction equations for RASP data are presented in Table S1.
5Table S1 RASP RVRTC prediction equations
RASP
FEV0.5
M exp(5.7153-3794/(Length^2)+0.1892*LN(Age))
L 1
S 0.1776
FVC
M exp(6.9725-136.49/Length+0.2185*LN(Age))
L 1
S 0.1760
FEV0.5/FVC
M exp(0.0678-0.0036*Length+0.296/Age)
L 3.3441095
S exp(-3.4119+0.2366*LN(Age))
FEF25-75
M exp(4.0381+0.0034*Length-0.1057*Sex)
L 0.9032
S 0.2642
FEF75
M exp(6.9172–5077/(Length^2)-0.1577*Sex)
L 0.6822
S 0.317
Abbreviations: L: lambda (skewness); M: mu (mean); S: sigma (coefficient of variation); Length: Length in cm; Age: Age in weeks;
LN: natural logarithm. Sex: Girl = 0; Boy=1; These reference equations are only valid for subjects between 4-59 weeks of age and
50-79 cm in length.
A comparison of RVRTC data from healthy infants and young children according to published and new equipment-
specific equations is presented in Figure S2. It can be seen that while many healthy infants fall outside the 95%
‘normal range’ (i.e. 13% for FEV0.5, 10% for FVC and 17% for FEF25-75) and could therefore be misclassified as
‘abnormal’ when using the Jones equations,[8] once the new equipment-specific equations are applied, 95% subjects
fall within the normal range.
6Figure S2 RVRTC data from healthy infants and young children plotted against age according to Jones et al[8] and
the new equipment-specific equations
The dashed horizontal lines denote the upper and lower limit of normality. Within a healthy population, provided appropriate
reference equations are applied, 95% of results should lie within ±1.96 z-scores of the predicted range.
7Based on the new Jaeger® equations, fitted centiles with the corresponding upper and lower limits for the RVRTC
outcomes are illustrated in Figure S3.
Figure S3 Fitted centiles for RVRTC outcomes based on the new Jaeger equations
Fitted centiles for FEV0.5, FVC and FEV0.5/FVC were plotted against age as the spread (S) for these outcomes is age dependent. As
the median (M) for FEV0.5 and FVC is age and length dependent, the fitted centiles are shown for infants who may be of average
length for age (50th percentile [RED solid lines]), short (0.5th percentile [GREEN dotted lines]) or tall (99.5th percentile [BLUE
dashed lines]) for age. Bold lines indicate median values while thinner lines indicate upper and lower limit of the respective
median (5th and 95th centile: ±1.65 SD). For example: at 1 year of age, for an infant whose length is at the 50th percentile,
predicted average (95%CI) for FVC is 420 mL (315; 526); whereas the corresponding FVC would be 358 mL (268; 448) for a short-
for-age infant (0.5th centile for length) and 482 mL (361; 604) for one who is tall-for-age (99.5th percentile for length). FEV0.5/FVC
and FEF%, are also sex dependent, thus the fitted centiles are plotted for boys (BLUE solid lines) and girls (RED dotted lines) vs.
length as the spread (S) was not age dependent.
8Comparison of Jaeger® results between centres
A comparison of RVRTC outcomes from the four centres collected using the Jaeger Babybody and
expressed as z-scores using the new equipment-specific reference equations is shown in Figure S4.
Although the limited number of infants from Portugal and Australia precluded any formal analysis,
the majority of individual observations from all centres fell within ±2 z-scores. The distribution of
FEV0.5 results was very similar in the larger UK and Spanish datasets, but slightly lower FVC (and
hence higher FEV0.5/FVC and FEF25-75) were observed among the Spanish infants. Despite this being
the largest collation of RVRTC data from healthy infants to date, sample size was still relatively small
to undertake inter-centre comparisons with any confidence, since differences of up to 0.5 z-scores
can occur by chance within the same dataset due to sampling error when there are less than 300 per
group (i.e. 150 boys and 150 girls).[7]
Figure S4 Comparison of RVRTC outcomes collected using the Jaeger® Babybody and
expressed as z-scores using the new equipment-specific reference equations
The horizontal line within the UK and Spanish data denotes the mean value for the group.
9Impact of smoking status on RVRTC outcomes
For infants studied using RASP, lower flows were observed among the 44% exposed to tobacco
smoke, as reported previously (Table S2).[9,10] By contrast, no significant associations were
identified between RVRTC outcomes and tobacco smoke exposure in infants studied using the
Jaeger® device, probably reflecting the low exposure (18%) within this group.
Table S2 Impact of tobacco smoke exposure on healthy infants
RASP Jaeger®
Smoking
exposure
YES
Smoking
exposure
No
Mean (95%CI)
difference
(Yes-No)
Smoking
exposure
YES
Smoking
exposure
No
Mean (95%CI)
difference
(Yes-No)
n 140 (44%) 176 (56%) 59 (18%) 262 (82%)
zFEV0.5 -0.07 (1.05) 0.06 (0.96) -0.13 (-0.36; 0.09) 0.15 (1.04) -0.04 (0.99) 0.19(-0.09; 0.48)
zFVC -0.03 (1.05) 0.03 (0.97) -0.06 (-0.28; 0.16) 0.01 (1.05) -0.01 (1.0) 0.02 (-0.27; 0.30)
zFEV0.5/FVC -0.14 (1.00) 0.11 (0.99) -0.26 (-0.48; -0.04)* 0.16 (0.93) -0.04 (1.02) 0.20 (-0.08; 0.48)
zFEF25-75 -0.15 (0.99) 0.12 (0.99) -0.28 (-0.50; -0.05)* 0.16 (0.90) -0.04 (1.02) 0.21 (-0.08; 0.49)
Bold fonts indicate significant differences between smoking exposure groups. * p<0.05.
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